Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-077763
Filing Date
2021-06-07
Accepted
2021-06-07 17:01:38
Documents
1
Period of Report
2021-06-04

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2119042d1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2119042d1_4seq1.xml 4 3890
  Complete submission text file 0001104659-21-077763.txt   5314
Mailing Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452
Business Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452 781-788-9043
EYEGATE PHARMACEUTICALS INC (Issuer) CIK: 0001372514 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EYEGATE PHARMACEUTICALS, INC. 271 WAVERLY OAKS ROAD, SUITE 108 WALTHAM MA 02452
Business Address
Mann Brenda (Reporting) CIK: 0001668858 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36672 | Film No.: 211000218